Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-13 4:48 pm Purchase | 2026-11-06 | 13G | INMED PHARMACEUTICALS INC INM | Commodore Capital LP | 2,977,630 5.600% | 2,977,630 (New Position) | Filing History |
| 2026-11-13 4:06 pm Purchase | 2026-11-06 | 13G | INMED PHARMACEUTICALS INC INM | Deep Track Capital, LP | 2,977,478 5.640% | 2,977,478 (New Position) | Filing History |
| 2026-11-12 5:00 pm Purchase | 2026-11-06 | 13D | INMED PHARMACEUTICALS INC INM | Fairmount Funds Management LLC | 10,555,507 19.990% | 10,555,507 (New Position) | Filing History |
| 2026-10-07 6:00 pm Purchase | 2026-09-30 | 13G | INMED PHARMACEUTICALS INC INM | ADAR1 Capital Management LLC | 943,668 17.200% | 143,668 (+17.96%) | Filing History |
| 2026-08-14 9:12 pm Purchase | 2026-06-30 | 13G | INMED PHARMACEUTICALS INC INM | Ikarian Capital, LLC | 137,634 4.200% | 137,634 (New Position) | Filing History |
| 2026-06-10 9:32 pm Purchase | 2026-05-19 | 13D | INMED PHARMACEUTICALS INC INM | Vivo Opportunity Fund Holdings, L.P. | 718,444 21.700% | 718,444 (New Position) | Filing History |
| 2026-06-05 4:44 pm Purchase | 2026-05-31 | 13G | INMED PHARMACEUTICALS INC INM | ADAR1 Capital Management LLC | 800,000 24.100% | 800,000 (New Position) | Filing History |
| 2026-05-27 4:08 pm Purchase | 2026-05-19 | 13G | INMED PHARMACEUTICALS INC INM | Squadron Master Fund LP | 325,000 9.800% | 325,000 (New Position) | Filing History |
| 2026-01-20 2:25 pm Purchase | 2025-12-31 | 13G | INMED PHARMACEUTICALS INC INM | SABBY MANAGEMENT LLC | 280,138 9.900% | 244,003 (+675.25%) | Filing History |
| 2025-04-02 4:13 pm Sale | 2025-03-31 | 13G | INMED PHARMACEUTICALS INC INM | AdvisorShares Trust | 0 0.000% | -36,665 (Position Closed) | Filing History |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | INMED PHARMACEUTICALS INC INM | SABBY MANAGEMENT LLC | 36,135 4.900% | 9,886 (+37.66%) | Filing History |
| 2024-12-18 08:05 am Purchase | 2024-12-13 | 13G | INMED PHARMACEUTICALS INC INM | YA II PN, Ltd. | 80,372 9.990% | 80,372 (New Position) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | INMED PHARMACEUTICALS INC INM | Armistice Capital, LLC | 696,318 4.990% | 666,007 (+2197.25%) | Filing History |
| 2024-11-12 1:44 pm Purchase | 2024-09-30 | 13G | INMED PHARMACEUTICALS INC INM | AdvisorShares Trust | 36,665 8.770% | 36,665 (New Position) | Filing History |
| 2024-02-14 2:28 pm Purchase | 2023-12-31 | 13G | INMED PHARMACEUTICALS INC INM | Armistice Capital, LLC | 30,311 9.990% | 22,027 (+265.90%) | Filing History |
| 2024-01-03 5:43 pm Purchase | 2023-12-31 | 13G | INMED PHARMACEUTICALS INC INM | SABBY MANAGEMENT LLC | 26,249 11.000% | 26,249 (New Position) | Filing History |
| 2023-02-14 12:58 pm Purchase | 2022-12-31 | 13G | INMED PHARMACEUTICALS INC INM | Armistice Capital, LLC | 8,284 9.990% | 8,284 (New Position) | Filing History |
| 2022-02-04 3:29 pm Purchase | 2021-12-31 | 13G | INMED PHARMACEUTICALS INC INM | Hudson Bay Capital Management LP | 1,120 3.810% | 231 (+25.98%) | Filing History |